Gene-drug interactions (data source: DGIdb)
Gene Name Entrez ID Drug Name Chembl ID Interaction Types Sources publications

Variant-drug associations (data source: PharmGKB)
Gene Name Variant Alleles Chemical Phenotype Category Significance Notes Sentence Publications Annotation ID
TEX10 rs7035619 A duloxetine efficacy yes Variant was suggestively significant, but did not reach genome-wide significance. Response was defined by >50% decrease in Montgomery-Asberg Depression Rating Scale (MADRS) score at the end of treatment. Allele A is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele T. 29407288 1449167906
TEX10 rs7472 G duloxetine efficacy yes Variant was suggestively significant, but did not reach genome-wide significance. Response was defined by >50% decrease in Montgomery-Asberg Depression Rating Scale (MADRS) score at the end of treatment. Allele G is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele A. 29407288 1449167912
TEX10 rs10124893 G duloxetine efficacy yes Variant was suggestively significant, but did not reach genome-wide significance. Response was defined by >50% decrease in Montgomery-Asberg Depression Rating Scale (MADRS) score at the end of treatment. Allele G is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele A. 29407288 1449167888
TEX10 rs10989064 T duloxetine efficacy yes Variant was suggestively significant, but did not reach genome-wide significance. Response was defined by >50% decrease in Montgomery-Asberg Depression Rating Scale (MADRS) score at the end of treatment. Allele T is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele C. 29407288 1449167894
TEX10 rs6479008 C duloxetine efficacy yes Variant was suggestively significant, but did not reach genome-wide significance. Response was defined by >50% decrease in Montgomery-Asberg Depression Rating Scale (MADRS) score at the end of treatment. Allele C is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele A. 29407288 1449167900